800-289-7930 info@rx30.com

Rx30 and Computer-Rx Announce New Medication Management Contact Center, Enhanced Medication Services Center

Enhanced Medication Services Center drives maximum patient engagement in medication management services, outcomes and delivery of STAR ratings. Orlando, FL April 24, 2017 – Rx30 and Computer-Rx, the leader in pharmacy management systems, today announced the launch of its new Enhanced Medication Services (EMS) center, a 26,000-square foot clinical services center, located in Orlando, FL. The new EMS center, staffed by highly trained technicians and clinical pharmacists, provides high-quality, clinical intervention outreach services to patients and providers in collaboration with pharmacies and health plans. EMS works with patients to ensure they take their medications and resolve medication-related problems. EMS engages providers to facilitate needed prescription updates and changes. EMS interventions provide “quality lift” for the pharmacies and health plans to achieve high ratings on performance measures and improve health outcomes. EMS services include comprehensive medication therapy management, refill sync coordination, medication adherence outreach, pharmacogenomics consulting and other targeted interventions to patients, providers, and pharmacies. Steve Wubker, President/CEO of Transaction Data Systems, Inc. (Rx30/Computer-Rx) states, “We are thrilled to bring this premier outreach center to our Rx30 and Computer-Rx pharmacies. Independent pharmacies today are judged by their patient’s adherence, yet many don’t have the time, staff and resources to devote to it, especially when the revenue formula still doesn’t fully support such activities. It’s been my vision to take this burden off the pharmacies by getting them off the ground through our own Enhanced Medication Services Center. EMS is like an extension of their pharmacy.” “EMS is excited to partner with the independent pharmacy market and bring an enhanced model that provides maximum patient engagement and effectiveness of medication management services.” states...

Rx30 and Computer-Rx Announce Strategic Combination

OCOEE, Fla. and MOORE, Okla., Oct. 6, 2016 /PRNewswire/ — Rx30 (or the “Company”) announced today that it has combined with Computer-Rx. Rx30, headquartered in Ocoee, Florida, is a leading developer and supplier of pharmacy management software solutions to the independent retail, hospital, long-term care and specialty pharmacy markets. Computer-Rx, headquartered in Moore, Oklahoma, is an innovative pharmacy software platform also focused on community pharmacies. Steve Wubker, CEO of Rx30, will lead the combined businesses. Roger Warkentine, Founder of Computer-Rx, will continue as an advisor to the combined business, and Lauren Warkentine, current COO of Computer-Rx, will become President of Computer-Rx. The rest of the Computer-Rx and Rx30 leadership teams will remain in place. Each platform will continue to run independently, investing in improving its offerings and leveraging the combined experience and innovations of both companies. “The combination of Rx30 with Computer-Rx brings together two of the most well-respected, fastest growing pharmacy platforms in the industry,” stated Mr. Wubker.  “Combining our pharmacy, data analytics and medication therapy management assets together will give Rx30 and Computer-Rx users scale and voice the industry has not seen previously.  The value we intend to bring to our combined user bases is very exciting.” “This combination brings together two companies that have the same mission, similar cultures and a shared passion to move our customers and the space forward,” added Ms. Warkentine.  “Building on the Warkentine family’s long-term commitment to building relationships with every pharmacy we serve, we believe this combination will create new opportunities for revolutionary innovation for community pharmacies that highlight their value in the healthcare system.” The combined Company’s headquarters will be...

Alpha Genomix and Rx30 Partner to Provide Personalized Medication Therapy

Ocoee, FL, September 30, 2016 – Rx30 is announcing a first to market, actionable pharmacogenetic platform through Alpha Genomix Laboratories that will allow the pharmacist and physician to work collaboratively towards a true personalized medicine approach within their communities.  We have established an exclusive agreement with Alpha Genomix Laboratories, a leader in the field of precision medicine, to integrate an actionable, real-time approach to pharmacogenetics specifically for the independent pharmacist. Pharmacogenetics can be the key differentiator in a pharmacies medication management, MTM, and overall patient care programs.  Our, “myRightMeds” program will help pharmacists select only those patients truly needing the testing, and then integrate patient selection, reporting and future guidance into their Rx30 system. “We are thrilled to empower Rx30 pharmacists in providing their patient population with a personalized medication treatment plan. By integrating industry leading genetic testing protocols with the most widely utilized pharmacy management software, we now have the capabilities to eliminate a significant amount of adverse events, trial and error, and waste within our country’s healthcare system. This is also an exciting opportunity for pharmacists to pinpoint effective patient care, differentiate in their quality of care, and be a shining example of leadership in implementing advanced programs for improved patient outcomes in this new era of Pay for Performance contracting.  We’re committed to help integrate Alpha Genomix exclusively for Rx30 pharmacies and their patients,” stated Steve Wubker, President and Chief Executive Officer of Rx30. “Alpha Genomix is proud to partner with RX30, the Nation’s leading pharmacy management software company, to deliver actionable pharmacogenetic testing to clinicians.  For years, experts have predicted that PGT would become standard of...

Rx30 Acquires Lagniappe Pharmacy Services (LPS)

MAY 17, 2016 — OCOEE, FL. — Transaction Data Systems, Inc., doing business as Rx30 (“Rx30” or the “Company”) announced today that it has completed the acquisition of Lagniappe Pharmacy Services (“LPS”). Rx30, headquartered in Ocoee, Florida, is a leading developer and supplier of pharmacy management software solutions to the independent retail, hospital, long-term care and specialty pharmacy markets. Steve Wubker, CEO of Rx30, and the existing Rx30 management team will lead the combined businesses. Christina McCormack, SVP of Operations for LPS, will join the Rx30 management team and continue to lead the LPS business line. “The acquisition of Lagniappe Pharmacy Services represents a significant and exciting step forward for Rx30 and LPS users, and represents Rx30’s ongoing commitment to the independent retail, chain, grocery, specialty, hospital, long-term care and health plan pharmacy markets,” stated Mr. Wubker. “We are committed to providing our pharmacies unparalleled leadership in innovation, functionality, outstanding customer support and product development that constantly moves the state of the industry forward.  This acquisition and the recently completed acquisition of vMEDEX, which created Rx30’s new Clinical Services Division, demonstrate that Rx30 is truly an industry leader on the move.” Ms. McCormack said, “We and the entire LPS team are excited to join Rx30. We look forward to bringing industry-leading pharmacy management software and other technologies to our combined customer base.” Dedicated to the independent pharmacy market for the last 38 years, Rx30 offers a suite of market-leading software solutions to enable prescription filling, pharmacy management and other critical functions for its pharmacist customers. The Company has deep expertise in providing cutting-edge technology solutions to help pharmacy owners...

Asembia and Rx30 Partner to Provide Integration for Asembia1 Specialty Pharmacy Platform

Asembia (Formerly Armada Health Care) is pleased to announce a partnership with Rx30 for the integration of Asembia1 (Formerly ArmadaOne) with their pharmacy dispensing system. “Rx30 works with pharmacies throughout the country, including specialty pharmacies, hospitals, health systems and beyond. We are excited to integrate Asembia1 with their system for these companies to streamline access to its functionality and key features as they expand their specialty business,” stated Lawrence Irene, RPh, chief executive officer of Asembia. “Since their original founding as Armada Health Care more than a decade ago, Asembia has been a catalyst in the specialty channel. The integration with Asembia1 will play a critical role for our mutual customers who are dispensing specialty pharmaceuticals and caring for patients requiring high-touch services,” stated Steve Wubker, president and chief executive officer of Rx30. Asembia1 is an integrated web-based software platform that optimizes specialty pharmacy operations, prescription workflow, and overall patient management. Asembia has developed this platform to seamlessly integrate with pharmacy dispensing systems and workflows used by specialty pharmacies across the country. Key features include onboarding specialty patients, streamlined management for prior authorizations, connectivity with co-pay and patient assistance programs, and ongoing clinical consultation and compliance monitoring. Other benefits include real-time data reporting for Pharma/biotech manufacturers, health plans, prescribers, and other industry partners. Asembia1’s robust business intelligence also provides prescription status information, operational insights, and other essential pharmacy management and productivity reports. (Source...

Rx30 Acquires vMEDEX, Strengthening Clinical Services Division and Product Offerings

OCOEE, Fla. –(BUSINESS WIRE)–Transaction Data Systems, Inc., doing business as Rx30 (“Rx30” or the “Company”) announced today that Rx30 has completed its acquisition of vMEDEX, further strengthening its Clinical Services Division and bringing new and innovative SaaS-based Medication Therapy Management and STAR Rating Management capabilities to its customers. Rx30, headquartered in Ocoee, Florida, is a leading developer and supplier of pharmacy management software solutions to the independent, hospital, long-term care and specialty pharmacy markets. Steve Wubker, CEO of Rx30, and the existing Rx30 management team will continue to lead the Company. The vMEDEX development team has joined Rx30 and will continue to lead development on the vMEDEX suite of clinical products. As Steve explains, “We are excited to bring the vMEDEX platform into the Rx30 suite of products to make available to our growing base of 4,400 independent pharmacies. vMEDEX has been a valued integration partner over the past 3 years, demonstrating an innovative approach to providing advanced clinical services functionality that position Rx30 pharmacies as industry leaders in this new era of pay for performance reimbursement. Combining our resources, expertise and platforms, we welcome the vMEDEX team into the Rx30 family and look forward to bringing our stores unparalleled functionality that maximizes favorable contracts and reimbursement levels. It’s a great time to be an Rx30 user!” Dedicated to the independent pharmacy market for the last 38 years, Rx30 offers a suite of market-leading software solutions to enable prescription filling, pharmacy management, claims processing and other critical functions for its pharmacist customers. The Company has deep expertise in providing cutting-edge technology solutions to help pharmacy owners streamline their operations,...